Mounjaro 7.5mg injection price: what you're actually deciding

What 7.5mg means in the titration, and why it matters to the price conversation

Mounjaro is licensed in six strengths: 2.5, 5, 7.5, 10, 12.5 and 15mg. Treatment begins at 2.5mg because the body needs time to adjust; the first pen's job is tolerability, not maximum effect. Most people move through 5mg before reaching 7.5mg, typically after around eight weeks, though the prescriber decides the pace based on how you're responding. By the time you're at 7.5mg, you're into the range where meaningful therapeutic effect tends to build.

The reason this matters to price is straightforward: higher doses cost more per pen across most private providers in the UK. That stepped cost structure is worth factoring into any budget planning from the outset, not as a surprise when the next prescription lands. If you want to understand what the 7.5mg dose specifically costs across private providers, our dedicated pricing page covers the detail you need. If you want a broader overview of how pricing works across the full range, our page on Mounjaro injection costs in the UK sets out the full picture. For context on where 7.5mg sits relative to the starting dose, the 2.5mg pricing page covers the beginning of that journey.

One checking habit worth developing before you commit to any provider: open the GPhC pharmacy register and search the seller's registration number. It takes under a minute and confirms whether a pharmacy is properly registered. If there's no registration number displayed on the site at all, that's a meaningful red flag.

What a headline 7.5mg price may or may not include

Private Mounjaro prices are quoted in very different ways, and comparing them at face value can mislead. Some providers show a per-pen figure that doesn't include the initial consultation fee, which can itself run to £30–£80 or more elsewhere. Others charge separately for the prescription, for each follow-up clinical review, or for delivery. A low headline number can become considerably higher once those line items appear at checkout.

Aftercare is worth particular attention at 7.5mg. This is a dose at which some people experience a recurrence of GI side effects (nausea, constipation, disrupted appetite) that settled during earlier titration. Having a prescriber reachable to discuss whether to slow the titration, adjust timing, or simply reassure you isn't a luxury; it's part of responsible prescribing. The NHS patient information for tirzepatide is clear that the medicine works within a supervised clinical framework, and NICE's recommendation under TA1026 reinforces that clinical review is integral, not optional.

It's also worth noting that at 7.5mg you may be approaching a dose increase to 10mg. Responsible services require clinical evidence before stepping up, that review should be included, not billed separately. Our 5mg pricing page covers the transition considerations one step earlier, and the 12.5mg page addresses what comes next.

How nume prices this, and why we're deliberately not the cheapest

One transparent price at nume covers the consultation, the prescription, the treatment itself, and free next-working-day tracked delivery via DPD in plain packaging. There are no line items for aftercare access or repeat clinical reviews. We don't offer discount codes, promotional pricing or subscription plans that lock you in before a prescriber has seen how you're doing, and we never will. Every repeat order goes back to a real prescriber for a fresh review.

We're honest about where that leaves us on price comparison sites: we're not at the bottom of the list, and we made that choice deliberately. For a prescription medicine, the lower the price the more it's worth asking what's been removed to get there. Legitimate, clinically supervised treatment through a licensed UK supply chain costs what it costs. A small saving on a single pen isn't the measure that keeps you safe over a course of treatment that may run many months.

If you're thinking about the longer-term cost trajectory, our page on whether Mounjaro's cost is changing covers the market context in more detail. And for the full clinical picture on what Mounjaro is, how it works, and who it's licensed for, the Mounjaro overview is the place to start.

Why price is the wrong filter when you're choosing a prescriber

Mounjaro is a prescription-only medicine regulated by the MHRA. That means no legitimate source can supply it without a clinical assessment, which is also why the MHRA has had to warn publicly about counterfeit pens sold online and via social media, some containing insulin rather than tirzepatide. Large-scale enforcement operations have seized fake pens across the UK; you can report any suspect seller via the MHRA's Yellow Card scheme. The red flags are consistent: sellers offering these medicines without a prescription, prices conspicuously below the private market, and no verifiable GPhC registration.

The clinical assessment for 7.5mg isn't a formality. At this dose the prescriber should be reviewing your weight response, checking for side effects, confirming any co-existing conditions, and deciding whether the current titration pace is right for you. That conversation is where outcomes are shaped. A prescriber who has seen your full picture is not equivalent to a form-filling exercise that rubber-stamps a dose. Our clinical team page gives you a sense of who reviews consultations at nume, prescribers, not algorithms.

If you're ready to find out whether 7.5mg Mounjaro is clinically suitable for you, the next step is a free consultation through our treatment page. No commitment until you've spoken to a prescriber and know what the right path looks like.